for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up
Company News

BRIEF-ProMIS Neurosciences Announces Fiscal Year 2017 Annual Results

March 14 (Reuters) - ProMIS Neurosciences Inc:

* PROMIS NEUROSCIENCES ANNOUNCES FISCAL YEAR 2017 ANNUAL RESULTS

* PROMIS NEUROSCIENCES INC - TOP PRIORITY FOR 2018 TO CONTINUE TO PROGRESS DEVELOPMENT OF PMN310 FOR CLINICAL TRIAL INITIATION IN 2019

* PROMIS NEUROSCIENCES - IN 2018, WILL CONTINUE TO EXPAND PROGRAM TARGETING TDP43 IN ALS AND FTD AND ITS ALPHA-SYNUCLEIN PROGRAM FOR PD Source text for Eikon: Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up